IFNG and dermatitis: Three of the 19 patients with severe dermatitis (i.e., 5 mild, 2 moderate, and 12 subjects with severe dermatitis) had IFN-γ-producing cells reactive to benznidazole between 6 and 24 months after chemotherapy, but not before treatment or in uninfected subjects (UI; Fig. 2D).